Zanoboni A, Zecca L, Zanoboni-Muciaccia W
Clin Endocrinol (Oxf). 1983 Mar;18(3):233-9. doi: 10.1111/j.1365-2265.1983.tb03207.x.
We have investigated the effects of a single oral dose of L-Dopa (500 mg) or of an i.v. infusion of TRH (1 mg dissolved in 400 ml of saline solution) or both administered together, on GH release in men with alcoholic cirrhosis of the liver, and compared them with responses in normal subjects. The results obtained in normal subjects confirm that TRH does not modify plasma GH levels, L-Dopa elevates GH concentrations, while the administration of these two drugs together significantly inhibits GH release induced by oral L-Dopa. In contrast, in patients with alcoholic cirrhosis of the liver, the following results were obtained: 1 TRH infusion significantly increased plasma GH levels which were steadily elevated throughout the experiment; 2 oral administration of L-Dopa provoked a significant rise in blood GH over the basal values similar to that observed in normal subjects; 3 when TRH and L-Dopa are administered at the same time a GH increase like that observed after L-Dopa alone was obtained. These results clearly demonstrate that in patients with alcoholic cirrhosis of the liver the normal inhibitory effect of TRH on L-Dopa induced GH release is completely lost.
我们研究了单次口服左旋多巴(500毫克)、静脉输注促甲状腺激素释放激素(1毫克溶于400毫升盐溶液中)或两者同时给药对酒精性肝硬化男性患者生长激素释放的影响,并将其与正常受试者的反应进行了比较。在正常受试者中获得的结果证实,促甲状腺激素释放激素不会改变血浆生长激素水平,左旋多巴会升高生长激素浓度,而同时给予这两种药物会显著抑制口服左旋多巴诱导的生长激素释放。相比之下,在酒精性肝硬化患者中,获得了以下结果:1. 输注促甲状腺激素释放激素显著提高了血浆生长激素水平,在整个实验过程中该水平持续升高;2. 口服左旋多巴使血液生长激素水平比基础值显著升高,与正常受试者中观察到的情况相似;3. 当同时给予促甲状腺激素释放激素和左旋多巴时,获得了与单独给予左旋多巴后观察到的生长激素增加情况相同的结果。这些结果清楚地表明,在酒精性肝硬化患者中,促甲状腺激素释放激素对左旋多巴诱导的生长激素释放的正常抑制作用完全丧失。